Study limitations included the lack of generalizability to patients in later stages of ALS, risk of including ALS mimics, shorter treatment duration of 16 weeks vs the typical 24 weeks in other clinical trials, small sample size, and lack of evaluation of specific disease-related biomarkers
Use during pregnancy and lactation should be limited to cases where the benefits outweigh the risks, as high-dose parenteral administration has not been fully studied in these populations
Keep documentation tight so your team can adjust cadence and education as needed
Adres deiikliklerinde sayfamz otomatik olarak gncellenmektedir
Energy improvement: the timeline patients actually report Patient reviews that specify timing reveal a consistent pattern: Hours 0-12 post-injection: 23% report immediate "warmth" or "alertness" within 1-2 hours
Benefits include improved energy, better sleep, elevated mood (it raises serotonin), increased focus, hormone regulation, hair growth + so much more